The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy. This is being reported by an international team of researchers led by investigators at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai. In their new study, reported in the July 30 issue of the journal iCirculation/i, scientists demonstrated that gene ...Thursday, 1 August 2013
Inhalable Gene Therapy may Help Patients With Pulmonary Arterial Hypertension
The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy. This is being reported by an international team of researchers led by investigators at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai. In their new study, reported in the July 30 issue of the journal iCirculation/i, scientists demonstrated that gene ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment